The Catalyst

Most Recent Posts


Yesterday, I highlighted a nice video produced by PhRMA on the prescription drug life cycle. Today, I'd like to talk a bit more about the prescription drug life cycle concept portrayed in that video - a concept with which many people are unfamiliar.


If you haven't had a chance to see Eli Lilly's CEO Dr. John Lechleiter speak, I strongly encourage it. Dr. Lechleiter is a wonky, funny and brilliant former chemist who is a passionate stalwart on the issue of counterfeit drugs.

08.24.12 | By Erin Mullen

...that I was huddled in an interior bathroom in South Florida with my fiance, my sister's roommate and two golden retrievers. We had the radio tuned to hear local meteorologist Bryan Norcross' voice through the dark hours, but it wasn't loud enough to drown out the howling wind and random thumps and crashes against the house.


"Understanding the prescription drug life cycle and how it should affect public policy." That sounds like the title of an obscure 2:00pm, four cup of coffee on a Friday afternoon industry seminar.


As Washington Post's Lenny Bernstein notes in today's Wellness column, schools are starting to get serious about addressing childhood obesity. And it's about time, since obesity is one of the most insidious problems in health care.


The quest for a cure can be a rigorous process that is laden with a series of setbacks and failures. Fortunately, researchers use what they learn from each of these setbacks to advance the science one step closer to a breakthrough.


We often talk around here about the rising rates of chronic diseases (see here, here and the Partnership here) such as diabetes. Sadly, over four thousand Americans are diagnosed with diabetes each and every day.


As part of our "From Hope to Cures" guest blog series, today we have a post from Gary A.


When we first launched this blog, we made a promise to host an open and ongoing conversation about the role innovative medicines play in battling disease and reducing health care costs.

08.16.12 | By Greg Lopes

There is a great article in the latest issue of Health Affairs that demonstrates yet again that properly adhering to prescribed treatments not only improves our health, but saves money. The Harvard and Express Scripts researchers looked at diabetes patients over three years and found that improved adherence to diabetes medications reduced the odds of a subsequent hospitalization or emergency department visit by 13 percent.

08.13.12 | By Jay Taylor, By Jay Taylor

If you are like most people, I suspect you don't spend much time thinking about how international trade negotiations affect your health, job or the economy. I can't blame you. It's all pretty complex stuff that occurs without much press coverage or commentary.

But the outcomes of these negotiations matter and they can affect your access to medicines, your job and our economy.

That's why the on-going Trans-Pacific Partnership (TPP) negotiations should be on your radar.


Today we have a guest post from Dan Leonard, President of the National Pharmaceutical Council.


My first memory of listening to Bruce Springsteen my father play lullabies on his guitar, as I desperately tried to fight off sleep. Listening to Bruce and the E Street Band was as much a part of the fabric of my family as exchanging gifts at Christmas. We discussed his music the way we gossiped about family friends, and gifting a new album to my father was a sure-fire way to buy his love (just kidding, Dad).


Today, President Obama said in a speech in Colorado, "I believe in American workers, I believe in this American industry, and now the American auto industry has come roaring back.


While writing a response to Donald Lights' flawed analysis in the British Medical Journal, I came across an insightful blog post written by Derek Lowe of "In the Pipeline" fame.